xanthenes - CISMeF

Preferred Label : xanthenes;

MeSH definition : Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring.;

MeSH synonym : Xanthene;

MeSH annotation : do not confuse with XANTHINES;

Wikipedia link : https://en.wikipedia.org/wiki/Xanthenes;

Is substance : O;

Details

Origin ID

D014966;

UMLS CUI

C0043313;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Ne pas confondre avec
- xanthines [MeSH Descriptor]
Record concept(s)
- xanthenes [MeSH concept]
Related MeSH Supplementary Concept(s)
- (3,10-dihydroxybenz(c)xanthene-7-yl)-4-carboxy-2-methylbenzene [MeSH Supplementary Concept]
- (6-hydroxy-3-oxo-3H-xanthen-9-yl)methyl [MeSH Supplementary Concept]
- (9H-xanthene-9-carbonyl)carbamic acid butyl ester [MeSH Supplementary Concept]
- 1,2,4,5,7,8-hexachloro(9H)xanthene [MeSH Supplementary Concept]
- 1,4,-benzenedicarboxylic acid, 2-(10-(dimethylamino)-4-fluoro-3-oxo-3H-benzo(c)xanthen-7-yl) [MeSH Supplementary Concept]
- 1-(2,7-difluoro-6-hydroxy-4,5-bis(1,2,3-dithioarsolan-2-yl)-3-oxo-3H-xanthen-9-yl)-4-oxo-4H-quinolizine-3-carboxylic Acid [MeSH Supplementary Concept]
- 1-(9'-(o-carboxyphenyl)-6'-amino-2'-chloro-3'-xanthanone)-4,10-(diethyl)-7-(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecane [MeSH Supplementary Concept]
- 1-hydroxy-2,3,5-trimethoxyxanthene [MeSH Supplementary Concept]
- 14-epicochlioquinone B [MeSH Supplementary Concept]
- 14-epidihydrocochlioquinone B [MeSH Supplementary Concept]
- 1R,2R-dicamphanoyl-3,3-dimethydihydropyrano(2,3-c)xanthen-7(1H)-one [MeSH Supplementary Concept]
- 2'-O-tetrahydropyranyl-3',5'-O-di(9-phenylxanthenyl)adenosine [MeSH Supplementary Concept]
- 2,3,4,5,6-pentafluorodihydrotetramethylrosamine [MeSH Supplementary Concept]
- 2,3,4,6,8-pentahydroxy-1-methylxanthone [MeSH Supplementary Concept]
- 2,3,6,8-tetrahydroxy-1-methylxanthone [MeSH Supplementary Concept]
- 2,5,7-tribromo-4a-bromomethyl-1,1-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-xanthene [MeSH Supplementary Concept]
- 2,7-dibromo-4a-bromomethyl-1,1-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-xanthene [MeSH Supplementary Concept]
- 2-(-2-((3',6'-bis(diethylamino)-3-oxospiro(isoindoline-1,9'-xanthen)-2-yl)imino)ethylidene)-N-phenylhydrazine-1-carbothioamide [MeSH Supplementary Concept]
- 2-(1-amino-1-carboxy-2-(9H-xanthen-9-yl)-ethyl)-1-fluorocyclopropanecarboxylic acid, 6-heptyl ester [MeSH Supplementary Concept]
- 2-(1-amino-1-carboxy-2-(9H-xanthen-9-yl)ethyl)-1-fluorocyclopropanecarboxylic acid [MeSH Supplementary Concept]
- 2-(2,4,5,7-tetrabromo-3-oxido-6-oxoxanthen-9-yl)benzoate [MeSH Supplementary Concept]
- 2-amino-2-(3-carboxycyclobutyl)-3-(9H-xanthen-9-yl)propionic acid [MeSH Supplementary Concept]
- 2-amino-2-(4-carboxyphenyl)-3-(9H-xanthen-9-yl)propanoic acid [MeSH Supplementary Concept]
- 3'(R)-O-beta-D-glucopyranosyl-3',4'-dihydroxanthyletin [MeSH Supplementary Concept]
- 3',3''-bis(oxospiroisobenzofuran)-3,7-bis(diethylamino)benzopyrano-xanthene [MeSH Supplementary Concept]
- 3',4',5',6'-tetrachlorogallein-molybdenum(VI) complex [MeSH Supplementary Concept]
- 3',4'-deoxypsorospermin-4'-chloro-3'-ol [MeSH Supplementary Concept]
- 3',6'-bis(N-(2-(iodoacetamido)ethyl)-N-methylamino)spiro(isobenzofuran-1(3H)9'-(9H)xanthen)-3-one [MeSH Supplementary Concept]
- 3,5-dibromo-4-hydroxyphenylflurone [MeSH Supplementary Concept]
- 3-oxo-8,9b-bis(N(1)-acrylamidospermidyl)-1,2,3,4,4a,9b-hexahydroxanthene [MeSH Supplementary Concept]
- 3-quinuclidinyl 8-xanthenecarboxylate [MeSH Supplementary Concept]
- 3-quinuclidinyl xanthene-9-carboxylate [MeSH Supplementary Concept]
- 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene oxide [MeSH Supplementary Concept]
- 4,6-dimethoxy-9-(4-methoxybenzyl)-8-(2-(4-methoxyphenyl)ethyl)-9H-xanthene-2,3,5-triol [MeSH Supplementary Concept]
- 4-(2-((3',6'-bis(diethylamino)-3-oxospiro(isoindoline-1,9'-xanthene)-2-yl)ethylimino)methyl)benzonitrile [MeSH Supplementary Concept]
- 5,10-dihydroxy-2,2-dimethylpyrano(3,2-b)xanthen-6(2H)-one [MeSH Supplementary Concept]
- 6-deoxyisojacareubin [MeSH Supplementary Concept]
- 6-hydroxy-3-oxo-3H-xanthene-9-carboxylic acid [MeSH Supplementary Concept]
- 6-hydroxy-3-oxo-3H-xanthene-9-propionic acid [MeSH Supplementary Concept]
- 6-hydroxy-3-xanthen-3-one [MeSH Supplementary Concept]
- 6-methoxy-2-(4-(2-methoxyphenyl)piperazin-1-yl)-9H-xanthen-9-one [MeSH Supplementary Concept]
- 8-aminoxanthene [MeSH Supplementary Concept]
- 8-desooxygartanin [MeSH Supplementary Concept]
- 9,9'-spirobixanthene-1,1'-diol [MeSH Supplementary Concept]
- 9-(2'-carboxyphenyl)-4,5-dibromo-2,3,7-trihydroxy-6-fluorone-aluminum (III) complex [MeSH Supplementary Concept]
- 9-(2-hydroxy-4,4,-dimethyl-6-oxo-1-cyclohexen-1-yl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-one [MeSH Supplementary Concept]
- 9-(2-methylindol-3-yl)-4a-morpholino-7-nitro-1,2,3,4,4a,9a-hexahydroxanthene [MeSH Supplementary Concept]
- 9-(8-azabicyclo(3.2.1)oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide [MeSH Supplementary Concept]
- 9-(o-carboxyphenyl)-2-chloro-6-(bis(2-pyridylmethyl)amino)-3-xanthanone [MeSH Supplementary Concept]
- 9-oxoxanthen-2-yl-alpha-propionic acid [MeSH Supplementary Concept]
- AGI B4 [MeSH Supplementary Concept]
- AH7614 [MeSH Supplementary Concept]
- BRP-1 rhodamine platform [MeSH Supplementary Concept]
- BRP-2 rhodamine platform [MeSH Supplementary Concept]
- C.I. solvent green 4 [MeSH Supplementary Concept]
- CDg13 compound [MeSH Supplementary Concept]
- CyJ fluorescence probe [MeSH Supplementary Concept]
- FD 594, antibiotic [MeSH Supplementary Concept]
- Fluo-3 [MeSH Supplementary Concept]
- Fluo-5F-AM [MeSH Supplementary Concept]
- FluoZin-1 [MeSH Supplementary Concept]
- IB 00208 [MeSH Supplementary Concept]
- L 152804 [MeSH Supplementary Concept]
- LY 210073 [MeSH Supplementary Concept]
- LY 292728 [MeSH Supplementary Concept]
- LY 341495 [MeSH Supplementary Concept]
- LY 344545 [MeSH Supplementary Concept]
- LY366457 [MeSH Supplementary Concept]
- M119 compound [MeSH Supplementary Concept]
- MI-401 [MeSH Supplementary Concept]
- Mito thermo yellow [MeSH Supplementary Concept]
- N,N'-bis(2,7-di(tert-butyl)-5-cyano-9,9-dimethyl-9H-xanthen-4-yl)-1,4,5,8-naphthalenetetracarboxylic-1,8(4,5)-diimide [MeSH Supplementary Concept]
- N-(9-(4-(bis(2-(ethylthio)ethyl)amino)phenyl)-6-(diethylamino)-3H-xanthen-3-ylidene)-N-ethylethanaminium [MeSH Supplementary Concept]
- N-(Texas red sulfonyl)-5-dodecanoylamine [MeSH Supplementary Concept]
- N-(Texas red sulfonyl)-6-dodecanoylamine [MeSH Supplementary Concept]
- N-hydroxy-9H-xanthene-9-carboxamide [MeSH Supplementary Concept]
- NIR-HS compound [MeSH Supplementary Concept]
- QSY-9 [MeSH Supplementary Concept]
- RU 31156 [MeSH Supplementary Concept]
- RhodZin-3 [MeSH Supplementary Concept]
- SCH 42137 [MeSH Supplementary Concept]
- SD 1029 [MeSH Supplementary Concept]
- TG-Phos compound [MeSH Supplementary Concept]
- Texas Red 1,2-dipalmitoyl-sn-glycero-phosphoethanolamine [MeSH Supplementary Concept]
- UCB 35625 [MeSH Supplementary Concept]
- Ugonstilbene B [MeSH Supplementary Concept]
- actinoplanone A [MeSH Supplementary Concept]
- actinoplanone B [MeSH Supplementary Concept]
- actinoplanone C [MeSH Supplementary Concept]
- actinoplanone D [MeSH Supplementary Concept]
- actinoplanone E [MeSH Supplementary Concept]
- actinoplanone F [MeSH Supplementary Concept]
- actinoplanone G [MeSH Supplementary Concept]
- adxanthromycin A [MeSH Supplementary Concept]
- adxanthromycin B [MeSH Supplementary Concept]
- albofungin [MeSH Supplementary Concept]
- angelichalcone [MeSH Supplementary Concept]
- austalide K [MeSH Supplementary Concept]
- barceloneic acid C [MeSH Supplementary Concept]
- benzoselenoxanthenes [MeSH Supplementary Concept]
- blumeaxanthene II [MeSH Supplementary Concept]
- chamuvaritin [MeSH Supplementary Concept]
- chloroalbofungin [MeSH Supplementary Concept]
- chromazonarol [MeSH Supplementary Concept]
- cladoxanthone A [MeSH Supplementary Concept]
- clavizepine [MeSH Supplementary Concept]
- demethylbellidifolin [MeSH Supplementary Concept]
- dencryol A [MeSH Supplementary Concept]
- dencryol B [MeSH Supplementary Concept]
- desmethylbellidifolin [MeSH Supplementary Concept]
- dibenzoxanthenes [MeSH Supplementary Concept]
- diff quik [MeSH Supplementary Concept]
- ehretianone [MeSH Supplementary Concept]
- ergochromes [MeSH Supplementary Concept]
- fluo 4 [MeSH Supplementary Concept]
- fluo-8 AM [MeSH Supplementary Concept]
- gallein [MeSH Supplementary Concept]
- gallin [MeSH Supplementary Concept]
- garcinone E [MeSH Supplementary Concept]
- gaudichaudione A [MeSH Supplementary Concept]
- hamilxanthene [MeSH Supplementary Concept]
- hymeniacidin [MeSH Supplementary Concept]
- indigin [MeSH Supplementary Concept]
- isocowanol [MeSH Supplementary Concept]
- isogentisin 3-O-glucoside [MeSH Supplementary Concept]
- isojacareubin [MeSH Supplementary Concept]
- jacarelhyperol A [MeSH Supplementary Concept]
- jacarelhyperol B [MeSH Supplementary Concept]
- lysolipin I [MeSH Supplementary Concept]
- madeleinol A [MeSH Supplementary Concept]
- magnesium green [MeSH Supplementary Concept]
- mangostenol [MeSH Supplementary Concept]
- mangostenone A [MeSH Supplementary Concept]
- mangostenone B [MeSH Supplementary Concept]
- mercuryfluor-1 [MeSH Supplementary Concept]
- methyl fluorone black [MeSH Supplementary Concept]
- mitotracker orange [MeSH Supplementary Concept]
- neo-gambogic acid [MeSH Supplementary Concept]
- neohydnocarpin [MeSH Supplementary Concept]
- norathyriol [MeSH Supplementary Concept]
- ohioensin F [MeSH Supplementary Concept]
- ohioensin G [MeSH Supplementary Concept]
- ohioensin H [MeSH Supplementary Concept]
- onosmanone A [MeSH Supplementary Concept]
- onosmanone B [MeSH Supplementary Concept]
- piadar [MeSH Supplementary Concept]
- potassium iso-propylxanthate [MeSH Supplementary Concept]
- prim-O-glucosylcimifugin [MeSH Supplementary Concept]
- prooxen [MeSH Supplementary Concept]
- resazurin [MeSH Supplementary Concept]
- resorcinolnaphthalein [MeSH Supplementary Concept]
- rhodanile blue [MeSH Supplementary Concept]
- rhodomyrtosone E [MeSH Supplementary Concept]
- santalin [MeSH Supplementary Concept]
- santalin A [MeSH Supplementary Concept]
- sch 54445 [MeSH Supplementary Concept]
- securixanside A [MeSH Supplementary Concept]
- securixanside B [MeSH Supplementary Concept]
- securixanside C [MeSH Supplementary Concept]
- siccanin [MeSH Supplementary Concept]
- simonin A [MeSH Supplementary Concept]
- sundiversifolide [MeSH Supplementary Concept]
- tat-octreotate-fluorescein 5'-carboxylic acid [MeSH Supplementary Concept]
- texas Red-5-dCTP [MeSH Supplementary Concept]
- texas red [MeSH Supplementary Concept]
- thielocin A1alpha [MeSH Supplementary Concept]
- thielocin A1beta [MeSH Supplementary Concept]
- trans-tetrahydrobenzoxanthene [MeSH Supplementary Concept]
- trantelinium bromide [MeSH Supplementary Concept]
- umbilicaxanthoside A [MeSH Supplementary Concept]
- umbilicaxanthoside B [MeSH Supplementary Concept]
- vita blue [MeSH Supplementary Concept]
- watsonianone C [MeSH Supplementary Concept]
- wy 15297 [MeSH Supplementary Concept]
- xanthene-9-carboxylic acid [MeSH Supplementary Concept]
- xanthenone-4-acetic acid [MeSH Supplementary Concept]
- xanthohypericoside [MeSH Supplementary Concept]
- xanthommatin [MeSH Supplementary Concept]
- xanthydrol [MeSH Supplementary Concept]
- xantphos [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients